Skip to main content
OpenTrials
Completed

NCT Number: NCT00848133

A Comparison of Subvastus and Midvastus Approaches in Minimally-Invasive Total Knee Arthroplasty

The purpose of this study was to compare the early clinical outcomes of minimally invasive bilateral subvastus and midvastus approaches for total knee arthroplasty.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Total Knee Arthroplasty

Age range

40 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Bonutti Clinic

Effingham, Illinois, 62401, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with advanced bilateral osteoarthritis of the knee for treatment with total knee arthroplasty
  • patients who wish to undergo bilateral total knee arthroplasty as part of a single surgical procedure

Exclusion criteria

  • patients who were previously treated with knee arthroplasty

Treatment and study plan

mini-midvastus surgical approach for total knee arthroplasty

Procedure

mini-subvastus surgical approach for total knee arthroplasty

Procedure

Primary outcomes

  1. Knee Society Score

    Time frame: Final follow-up (minimum 24 months)

Secondary outcomes

  1. Radiographic alignment and fixation

    Time frame: Final follow-up (minimum 24 months)

Sponsors and collaborators

Lead sponsor

Sinai Hospital of Baltimore

Other

Collaborators

  • Bonutti Clinic

Registry information

Important dates

Study start
2004
Primary completion
2009
Study completion
2009
First posted
Feb 20, 2009
Registry last updated
Feb 20, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.